Naproxcinod

This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H21NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, V24GR4LI3I chemically known as 2-naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, 4-(nitrooxy)butyl ester, (.alpha.s)- but generally known as naproxcinod, which bears US NIH Compound Identifier 9884642. European Medicines Agency schedules Naproxcinod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30968. The term NAPROXCINOD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57). Most nations schedule naproxcinod under HS 29209090 and SITC 51639. As of Q4 2014, NAPROXCINOD remains the US FDA Preferred Term for this commodity. Naproxcinod bears US NLM identifiers UMLS ID C0915860 and NCI Concept Code C83989. SMILES: O(C(=O)C(C1CC2C(CC1)CC(OC)CC2)C)CCCCO[N](=O)O.